Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
OA13 - Therapeutics and Radiation for Small Cell Lung Cancer
- Type: Oral Abstract Session
- Track: Small Cell Lung Cancer/NET
- Presentations: 8
- Coordinates: 9/26/2018, 10:30 - 12:00, Room 203 BD
-
+
OA13.06 - Final Report of a Prospective Randomized Study on Thoracic Radiotherapy Target Volumes in Limited-stage Small Cell Lung Cancer with Radiation Dosimetric and Pathologic Analyses
11:25 - 11:35 | Presenter: Xiao Hu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.01 - Advanced NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 112
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.01-16 - Low Dose Apatinib Combined with EGFR-TKI in Treating Advanced NSCLC After First-Generation EGFR-TKIs Treatment Failure
12:00 - 13:30 | Presenter: mingda Chen
- Abstract
Loading... -
+
P3.01-47 - Clinical Characteristics and Outcome for Patients with Advanced Lung Adenocarcinoma Treated with First-Line Pemetrexed Plus Platinum
12:00 - 13:30 | Presenter: Xue Ji
- Abstract
Loading... -
+
P3.01-60 - A Novel MET D1246H Mutation After Progression of EGFR-TKI/MET Inhibitor Combined Therapy in a NSCLC Patient with Acquired MET Amplification
12:00 - 13:30 | Presenter: Ying Liang
- Abstract
Loading... -
+
P3.01-62 - A New Method for Non-Invasive Prediction of Radiotherapy: SDH5 Depletion Enhances Radiosensitivity by Regulating P53
12:00 - 13:30 | Presenter: Jun Liu
- Abstract
Loading... -
+
P3.01-67 - Integrated Network Analysis to Understand the Potential Mechanisms of Hydroxychlrorquine in Non-Small Cell Lung Cancer Treatment
12:00 - 13:30 | Author(s): Xin Lyu
- Abstract
Loading... -
+
P3.01-84 - The Association of CDKN2A Gene Mutation with Clinicopathological Features and Prognosis in Advanced Lung Cancer Patients
12:00 - 13:30 | Author(s): Ling Xu
- Abstract
Loading... -
+
P3.01-106 - Real-World Data to Evaluate the Clinical Benefit of NGS for Directing Lung Adenocarcinoma Treatment
12:00 - 13:30 | Presenter: Zhaoxia Wang
- Abstract
Loading... -
+
P3.01-115 - Liposomal Paclitaxel Versus Gemcitabine: Which is Better?
12:00 - 13:30 | Author(s): Liu Pan
- Abstract
Loading...
-
+
P3.03 - Biology (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 30
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.03-01 - BRAF V600 and Non-V600 Mutations in Chinese Lung Cancer
12:00 - 13:30 | Presenter: Yang Gao
- Abstract
Loading... -
+
P3.03-10 - Transcriptomic Differences Between Early and Late Stage Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Dongsheng Yue
- Abstract
Loading... -
+
P3.03-29 - The Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Hadas Sorotsky
- Abstract
Loading...
-
+
P3.04 - Immunooncology (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 29
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.04-09 - Analysis of Repertoire Features of T Cell Receptor in Treat-Naïve EGFR Wild-Type Lung Cancer Patients by High-Throughput Sequencing
12:00 - 13:30 | Presenter: Yangyang Liu
- Abstract
Loading... -
+
P3.04-20 - Correlation of Immune-Related Adverse Events and Response from Immune Checkpoint Inhibitors in Patients with Advanced NSCLC
12:00 - 13:30 | Presenter: Mike Sung
- Abstract
Loading...
-
+
P3.09 - Pathology (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 26
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.09-01 - PDL1 Profile of Filipino Lung Adenocarcinoma Patients Show Moderate Positivity and Low EGFR Correlation
12:00 - 13:30 | Presenter: Francisco III Maramara Heralde
- Abstract
Loading... -
+
P3.09-07 - Immunohistochemical Expression of Programmed Death-Ligand 1 in Diabetic Patients vs Non-Diabetics with Non-Small Cell Lung Cancer
12:00 - 13:30 | Author(s): Michael Phillip Zaleski
- Abstract
Loading...
-
+
P3.11 - Screening and Early Detection (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 26
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.11-27 - Lung Cancer Diagnosed at Age 50-54 Years: Survival as Poor as Older Patients
12:00 - 13:30 | Presenter: Ping Yang
- Abstract
Loading...
-
+
P3.13 - Targeted Therapy (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 35
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.13-21 - Apatinib Plus Icotinib as First-Line Therapy For EGFR Co-Mutations NSCLC in Chinese Patients: An Exploratory Study
12:00 - 13:30 | Presenter: Yanhong Shang
- Abstract
Loading...
-
+
P3.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 47
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.16-07 - The Impact of Clinical and Molecular Profile of Resected EGFR-Mutant Non-Small Cell Lung Cancer on the Risk of Developing Brain Metastases
12:00 - 13:30 | Presenter: Mor Moskovitz
- Abstract
Loading... -
+
P3.16-29 - Prediction of Lymph Node Metastases in Clinical T1aN0M0 Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Tung-Ming Tsai
- Abstract
Loading... -
+
P3.16-46 - The Comparison Between Non-Intubated and Intubated Thoracoscopic Resection for Pulmonary Nodule: A Meta-Analysis
12:00 - 13:30 | Presenter: Yaokai Wen
- Abstract
Loading...
-
+
P3.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 23
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.17-08 - Assessing Primary Lung Cancer Lesion Using Ratio Metrics of T1 and T2-Weighted Images in Magnetic Resonance Imaging
12:00 - 13:30 | Author(s): Bo Qiu
- Abstract
Loading... -
+
P3.17-13 - SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients with Stage IIIA(N2) NSCLC — A Multicenter Single-Arm Phase II Trial.
12:00 - 13:30 | Presenter: Sacha I Rothschild
- Abstract
Loading...
-
+
MA25 - Oligometastasis: Defining, Treating, and Evaluating
- Type: Mini Oral Abstract Session
- Track: Oligometastatic NSCLC
- Presentations: 12
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 203 BD
-
+
MA25.06 - RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit from Local Consolidative Treatment
14:05 - 14:10 | Presenter: Jia-Tao Zhang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.11 - Clinical and Molecular Predictors of Outcome in Patients with EGFR mutant NSCLC Brain Metastases treated with RT
14:40 - 14:45 | Presenter: Fabio Y Moraes
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
first
prev
